Shahzaib Akram: What Are We Actually Seeing When a Sickling Test Goes Positive?
Shahzaib Akram, Medical Laboratory Technologist at Allied Hospital, Faisalabad, shared on LinkedIn:
”What are we actually seeing when a Sickling Test goes positive?
As laboratory professionals, we perform qualitative tests daily.
But some of the simplest manual methods carry the most profound clinical weight.
Take the Sickling Test.
On paper, it relies on a straightforward mechanism: inducing hypoxia in a red blood cell sample to see if abnormal Hemoglobin S (HbS) polymerizes, distorting that smooth, flexible biconcave disc into a rigid crescent.
But when you look down the microscope and see those classic sickle shapes form, you aren’t just observing a chemical reaction.
You are looking at the exact microscopic pathology driving a medical emergency.
That rigid ‘logjam’ on the slide is the identical process that causes microvascular occlusion in a patient—starving tissues of oxygen, accelerating hemolysis (dropping an RBC’s lifespan from 120 days down to just 10–20 days), and triggering agonizing vaso-occlusive crises.
While advanced methods like HPLC and electrophoresis provide the final quantitative breakdown, the humble sickling test remains a vital frontline gateway for:
- Rapid Screening and Triage: Offering critical direction in acute care settings when time is of the essence.
- Kinetics Clues: Gauging sickling speed (rapid vs. prolonged) to offer immediate clinical hints distinguishing Sickle Cell Disease (HbSS) from Sickle Cell Trait (HbAS).
I’ve put together a comprehensive, deeply practical guide breaking down the exact physiology, diagnostic nuances, and clinical significance of the Sickling Test.
Whether you are a student mastering hematology or a tech looking for a solid diagnostic refresher, this resource is built for you.
Dive into the full clinical breakdown.
Let’s keep learning, practicing, and mastering lab science together.”

Stay updated with Hemostasis Today.
-
Jul 5, 2026, 21:474 Tips for Exercising with A Bleeding Disorder – Haemophilia Foundation Australia
-
Jul 5, 2026, 21:06Heghine Khachatryan: Toward Personalized Management of Glanzmann Thrombasthenia
-
Jul 5, 2026, 21:06Priyanka Kumari: IV Fluids and Isotonic Solution
-
Jul 5, 2026, 21:05Ahmed Rizq: Would You Thrombolyse a Stable Patient?
-
Jul 5, 2026, 21:03Emmanuel Obeng Ofori: Diagnosing Anaemia – Why Treating the Root Cause Matters More Than Simply Raising the Haemoglobin
-
Jul 5, 2026, 21:02Mohit Koladia: The Pharmacist’s Role in Stroke Prevention for Atrial Fibrillation
-
Jul 5, 2026, 20:22J. Meireles-Brandao: Exploring the Approach to Thrombophillias
-
Jul 5, 2026, 20:13Kavya Keerthana: The Platelet Count Everyone Calls ‘Reactive’ Until It Isn’t
-
Jul 5, 2026, 20:00Paul Kariuki: Why Altruism Isn’t Enough to Save Kenya’s Blood System